rxstat › Shortages › Alfuzosin
Alfuzosin shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Alfuzosin products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 26, 2026.
In shortage since
Feb 17, 2026
Est. full return
Jun 26, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-ALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02315866 · since Feb 17, 2026, est. end Jun 26, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-ALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02315866 · ended Jan 22, 2026 · Disruption of the manufacture of the drug.
ResolvedALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · SANIS HEALTH INC
DIN 02519844 · ended Feb 12, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ ALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02304678 · ended Jan 13, 2025 · Disruption of the manufacture of the drug.
ResolvedAURO-ALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · AURO PHARMA INC
DIN 02443201 · ended Dec 2, 2024 · Demand increase for the drug.
ResolvedALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · SANIS HEALTH INC
DIN 02519844 · ended Oct 21, 2024 · Disruption of the manufacture of the drug.
ResolvedAURO-ALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · AURO PHARMA INC
DIN 02443201 · ended Jul 16, 2024 · Demand increase for the drug.
ResolvedAPO-ALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02315866 · ended Jun 27, 2024 · Disruption of the manufacture of the drug.
ResolvedALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · SANIS HEALTH INC
DIN 02519844 · ended May 16, 2024 · Demand increase for the drug.
ResolvedSANDOZ ALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02304678 · ended May 13, 2024 · Delay in shipping of the drug.
ResolvedAPO-ALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02315866 · ended Mar 21, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-ALFUZOSIN
10MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02315866 · ended Dec 14, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 21 reports. All reports are on file with Health Canada.
What's happening
Alfuzosin is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Alfuzosin is classified under “DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY” (ATC G04CA).
Recent changes
Common questions
When will Alfuzosin be back in stock in Canada?
The latest manufacturer estimate is Jun 26, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Alfuzosin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All drugs used in benign prostatic hypertrophy shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.